Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
MicroRNA
100%
MiRNA Signature
100%
Leukemia Cell Lines
100%
Imatinib Therapy
100%
MicroRNA Signature
100%
Chronic Myeloid Leukaemia Cells
100%
MiR-493-5p
62%
Imatinib
50%
K562 Cells
37%
Expression Change
37%
Imatinib Response
37%
Chronic Myeloid Leukemia
25%
Imatinib Resistance
25%
Cell Growth
12%
Overexpression
12%
Tyrosine Kinase Inhibitor
12%
Biomarker Discovery
12%
Cytotoxicity
12%
Gene Silencing
12%
Transcriptome
12%
Potential Biomarkers
12%
Genome-wide Expression
12%
Integrative Analysis
12%
Growth Inhibition
12%
Experimental Validation
12%
Predictive Algorithm
12%
K562
12%
Potential Genes
12%
Differentially Expressed Transcripts
12%
Combined Expression
12%
Filtering Criteria
12%
Gene Expression Omnibus
12%
MiRBase
12%
Imatinib Sensitivity
12%
Expression Dataset
12%
Multiple Omics
12%
Single Pair
12%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Myeloid
100%
Messenger RNA
100%
Imatinib
100%
K562 Cells
28%
Tyrosine Kinase Inhibitor
7%
Candidate Gene
7%
Biomarker Discovery
7%
Gene Expression
7%
Transfection
7%
Gene Inactivation
7%
Downregulation and Upregulation
7%
MiRBase
7%
Cytotoxicity
7%
Cell Growth
7%
Growth Inhibition
7%
Tamsulosin
7%
Transcriptome
7%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Chronic Myeloid Leukemia
100%
Imatinib
100%
Messenger RNA
100%
Biological Marker
14%
Tamsulosin
7%
Protein Tyrosine Kinase Inhibitor
7%
Transcriptome
7%
Cytotoxicity
7%